Better diagnostic tools needed for biopsy-negative giant cell arteritis
- 18 November 2022
- journal article
- editorial
- Published by Elsevier in The Lancet Rheumatology
- Vol. 5 (1) , e8-e10
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Validation of the Southend giant cell arteritis probability score in a Scottish single-centre fast-track pathwayRheumatology Advances in Practice, 2021
- Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspectiveThe Lancet Rheumatology, 2021
- Giant cell arteritis and its mimics: A comparison of three patient cohortsSeminars in Arthritis and Rheumatism, 2020
- British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritisRheumatology, 2020
- Neural network and logistic regression diagnostic prediction models for giant cell arteritis: development and validationClinical Ophthalmology, 2019
- EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practiceAnnals of the Rheumatic Diseases, 2018
- Distinctions Between Diagnostic and Classification Criteria?Arthritis Care & Research, 2015